UCSD researchers part of team identifying potential Alzheimer’s drug candidate

UCSD PRESS RELEASE

Researchers at UCSD, the Medical University of South Carolina and American Life Science Pharmaceuticals of San Diego report that they have identified a potential new drug candidate for Alzheimer’s disease.

A paper detailing their findings has been published as an early online version and is scheduled for publication in the Sept. 6 issue of the Journal of Alzheimer’s Disease.

The researchers have demonstrated that oral administration of a cysteine protease inhibitor, E64d, not only reduces the build-up of β-amyloid (Aβ) in the brains of animal models for Alzheimer’s disease, but also results in a substantial improvement in memory deficit.

According to lead investigator Vivian Y. H. Hook, Ph.D., professor of the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences and professor of neurosciences, pharmacology and medicine at the UCSD School of Medicine, this is major news for scientists studying Alzheimer’s disease.

“The finding is especially exciting because E64d has previously been shown safe for use in humans, so we believe the compound has strong potential as a new therapy for Alzheimer’s disease,” said Hook.

Increased Aβ levels in the brain are associated with the development of memory loss and amyloid plaque, the hallmark of Alzheimer’s disease. Aβ peptides are “cut” out from a larger protein called the amyloid precursor protein (APP) by an enzymatic “scissor” called β-secretase, and aggregate to form plaques in the brain regions responsible for memory.

E64d reduces Aβ by inhibiting the β-secretase “scissors” from “cutting” the APP chain into smaller toxic Aβ peptides. But in this study, the researchers found that the compound actually increases the activity of a protease called BACE1 which, to date, has been regarded as the primary β-secretase. Instead, E64d appears to lower brain Aβ by inhibiting the β-secretase activity of another protease, Cathepsin B.

“The study indicates Cathepsin B as a new target for therapeutic inhibition of Aβ production and subsequent improved memory function,” said Hook. “This is an important finding because we show that β-secretase inhibition can occur with Cathepsin B inhibition and without BACE1 inhibition.”

The researchers studied both old and young transgenic Alzheimer’s disease mice, and found that memory loss improved in both. In young mice, feeding E64d prevented development of memory loss; in old mice with memory loss, it improved memory.

The study builds upon work published in March 2008 that first demonstrated that inhibitors of Cathepsin B resulted in improved memory and reduction of Aβ and amyloid plaque; but in that study, the drug was administered directly into the brains of AD mice. In the new study, oral administration of the drug was efficacious and could lead the way to clinical trials in humans.

Co-authors of the study were Gregory Hook, PhD, of American Life Science Pharmaceuticals in San Diego, and Mark Kindy of the Medical University of South Carolina, as well as the Ralph H. Johnson VA Medical Center, and Applied Neurotechnology, Inc., in Charleston, SD.

G. Hook is an employee and has equity in American Life Science Pharmaceuticals (ALSP); V. Hook is chair of ALSP’s scientific advisory board and holds equity in the company, and Kindy holds equity in Applied Neurotechnology, relationships disclosed to their institutions.

The study was supported in part by the National Institute on Aging of the National Institutes of Health and the Alzheimer’s Drug Development Foundation.

Related posts:

  1. UCSD med students learn residency assignments
  2. UCSD team identified 'over-triage' as area for health care cost savings potential
  3. UCSD study reveals visual pattern preference may indicate autism
  4. Parents, students rally for education at La Jolla elementary schools
  5. Donor steps up to cover La Jolla fireworks fee, but $20,000 still needed

Short URL: http://www.lajollalight.com/?p=42605

Posted by Staff on May 31, 2011. Filed under La Jolla, News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

La Jolla Community Calendar

Facebook

Bottom Buttons 1

Bottom Buttons 2

Bottom Buttons 3

Bottom Buttons 4

Bottom Buttons 5

Bottom Buttons 6

RSS North Coastal News

  • Solana Beach water district moving to mandatory water use restrictions August 22, 2014
    Customers of the Santa Fe Irrigation District — including residents of Rancho Santa Fe, Solana Beach and part of Fairbanks Ranch — will face mandatory restrictions on water use starting Sept. 5, in an effort to save water due to an ongoing statewide drought. The restrictions include a three-day-per-week watering schedule for all homes and businesses, a prohi […]
  • West Coast FC Classic Champs August 22, 2014
    Congratulations to Coach Beto Villela and the San Diego Surf BU11 Academy (Villela) team. The boys won the West Coast FC Classic Tournament last weekend, held in Mission Viejo. […]
  • Surf GU9 team takes first place in Orange County Kickoff classic August 22, 2014
    The Surf Soccer Club Academy GU9 team took first place in the 2014 Orange County Kickoff Classic (Girls U9 flight 1) on Aug. 16-17. […]